Pharma4Future SRL
The score of Pharma4Future shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +603 % Total assets +33 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma4Future's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jul 2026
- Year ended 31 Dec 2024filed on 17 Jun 2025
- Year ended 31 Dec 2023filed on 28 Jun 2024
- Year ended 31 Dec 2022filed on 10 Aug 2023
Pharma4Future's financial analysis
- Solvency11.2%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma4Future
Pharma4Future's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0776.403.737
- VAT number
- BE0776403737
- Peppol
- Registered · 0208:0776403737 · as of 04 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Oct 2021
- Registered office
- 1745 Opwijk
- Latest accounts
- 2025 · filed on 02 Jul 2026
- Activity
- Activities of holding companies (NACE 64210)
Pharma4Future (SRL) has been based in Opwijk since 2021, active in: activities of holding companies. For 2025, it reports a net profit of 246,977 € and equity of 563,772 €; its revenue is not published. Its solvency stands at 11.2%, below the median of its sector (55.6%).
Companies similar to Pharma4Future
Companies in the same business, of comparable size and area, outside its group.
- VDD Investissement Activities of holding companies Tournai · balance sheet €5.03m
- Westvlacre Activities of holding companies Dilsen-Stokkem · balance sheet €5.04m
- Dubeco Holding Activities of holding companies Oud-Turnhout · balance sheet €5.02m
- Gregoire Group Activities of holding companies Dilbeek · balance sheet €5.05m
- Drimic Activities of holding companies Ypres · balance sheet €5.02m
- Paraplu Activities of holding companies Bruges · balance sheet €5.01m
- DE Steenakker Activities of holding companies Ypres · balance sheet €5.01m
- Holding Home Samy Activities of holding companies Herstal · balance sheet €5.05m
Frequently asked questions about Pharma4Future
What is the revenue of Pharma4Future?
Pharma4Future files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma4Future?
In Belgium, the VAT number is the company number prefixed with BE: BE0776403737 for Pharma4Future, if the company is VAT-registered. Its company number (CBE) is 0776.403.737.
Where is the registered office of Pharma4Future?
According to the CBE register, the registered office of Pharma4Future is in 1745 Opwijk.
What is the equity of Pharma4Future?
At the close of the 2025 financial year, the equity of Pharma4Future amounts to 563,772 €, a solvency of 11.2% of total assets.
Who manages Pharma4Future?
The register lists 6 active mandates at Pharma4Future. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma4Future
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →